MSFT 446.34 -0.4528% AAPL 214.29 -1.0984% NVDA 135.58 3.512% GOOGL 175.09 -1.213% GOOG 176.45 -1.3033% AMZN 182.81 -0.6791% META 499.49 -1.4093% AVGO 1802.52 -1.4408% TSLA 184.86 -1.3764% TSM 179.69 1.3823% LLY 891.46 0.7288% V 273.62 0.9035% JPM 197.0 1.036% UNH 481.05 -1.672% NVO 140.8 0.3063% WMT 67.6 0.267% LVMUY 152.46 -1.7021% XOM 109.38 0.9413% LVMHF 762.0 -1.8041% MA 450.11 0.4463%

Cochlear Ltd

Healthcare AU COH


Last update at 2024-06-19T06:10:00Z

Day Range


52 Week Range



Income Statement


Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax 396.60M 393.80M 365.70M -271.10000M 365.60M
Minority interest - - - - -
Net income 300.60M 289.10M 326.50M -238.30000M 276.70M
Selling general administrative 203.90M 159.00M 112.20M 93.80M 94.80M
Selling and marketing expenses 606.50M 498.70M 444.10M 470.00M 450.90M
Gross profit 1448.10M 1237.30M 1087.40M 976.20M 1075.60M
Reconciled depreciation 80.90M 73.00M 79.50M 28.85M 38.50M
Ebit 406.00M 402.40M 377.70M -243.90000M 370.80M
Ebitda 486.90M 475.40M 457.20M -166.40000M 409.30M
Depreciation and amortization 80.90M 73.00M 79.50M 77.50M 38.50M
Non operating income net other - - - - -
Operating income 406.30M 380.90M 340.50M 219.70M 370.80M
Other operating expenses 570.60M 426.30M 307.00M 871.00M 1119.70M
Interest expense 9.40M 8.60M 12.00M 10.50M 5.20M
Tax provision 96.00M 104.70M 39.20M -32.80000M 88.90M
Interest income 7.10M 2.40M 3.60M 8.90M 4.50M
Net interest income 7.10M -6.20000M -8.40000M -10.50000M -4.50000M
Extraordinary items - - - - 0.00000M
Non recurring - - - - -
Other items - - - - -
Income tax expense 96.00M 104.70M 39.20M -32.80000M 88.90M
Total revenue 1936.10M 1648.30M 1497.60M 1320.60M 1426.70M
Total operating expenses 1136.20M 941.40M 855.40M 839.50M 768.60M
Cost of revenue 488.00M 411.00M 410.20M 344.40M 351.10M
Total other income expense net -3.30000M 31.10M 62.60M -476.40000M -5.20000M
Discontinued operations - - - - -
Net income from continuing ops 300.60M 289.10M 326.50M -238.30000M 276.70M
Net income applicable to common shares 300.60M 289.10M 326.50M -238.30000M 276.70M
Preferred stock and other adjustments - - - - -
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Total assets 2568.70M 2465.10M 2438.20M 2575.70M 1379.20M
Intangible assets 188.00M 135.40M 135.50M 139.40M 155.60M
Earning assets - - - - -
Other current assets 57.00M 79.00M 108.00M 88.20M 41.30M
Total liab 819.90M 779.40M 736.50M 1174.20M 653.30M
Total stockholder equity 1748.80M 1685.70M 1701.70M 1401.50M 725.90M
Deferred long term liab - 33.00M 53.30M 58.10M 50.40M
Other current liab 206.80M 161.80M 124.90M 192.10M 152.50M
Common stock 1250.30M 1276.60M 1276.60M 1272.40M 182.30M
Capital stock 1250.30M 1276.60M 1276.60M 1272.40M 182.30M
Retained earnings 555.40M 455.30M 367.20M 116.40M 558.90M
Other liab 79.30M 76.60M 101.60M 71.30M 115.50M
Good will 256.10M 257.10M 267.30M 270.90M 268.80M
Other assets 126.90M 220.30M 203.40M 212.30M 155.90M
Cash 555.50M 629.30M 609.60M 565.00M 78.60M
Cash and equivalents 555.50M 629.30M 609.60M 565.00M 78.60M
Total current liabilities 578.00M 527.60M 402.50M 817.50M 359.50M
Current deferred revenue 61.60M 54.70M 42.80M 47.00M 42.90M
Net debt -353.70000M -375.40000M -345.30000M 139.50M 103.00M
Short term debt 39.20M 78.70M 31.90M 419.10M 3.30M
Short long term debt - 42.60M - 393.10M 3.30M
Short long term debt total 201.80M 253.90M 264.30M 704.50M 181.60M
Other stockholder equity -1805.70000M -1731.90000M -1631.70000M -1388.80000M -15.30000M
Property plant equipment 447.20M 439.20M 428.50M 438.80M 166.50M
Total current assets 1361.50M 1327.00M 1230.00M 1477.50M 635.00M
Long term investments 97.30M 119.10M 199.50M 94.90M 47.80M
Net tangible assets 1304.70M 1326.20M 1352.20M 1049.30M 351.90M
Short term investments 90.80M 68.80M 27.30M 365.00M 365.00M
Net receivables 437.50M 348.50M 296.30M 235.50M 319.70M
Long term debt - 0.00000M 45.00M 79.90M 178.30M
Inventory 311.50M 270.20M 216.10M 223.80M 195.40M
Accounts payable 270.40M 232.40M 202.90M 159.30M 160.80M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -56.90000M -46.20000M 57.90M 12.70M -15.30000M
Additional paid in capital - - - - -
Common stock total equity - - - 1272.40M 182.30M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 93.30M 71.20M 30.60M 7.10M 5.40M
Deferred long term asset charges - - - - -
Non current assets total 1207.20M 1138.10M 1208.20M 1098.20M 744.20M
Capital lease obligations 201.80M 211.30M 219.30M 231.50M -
Long term debt total 162.60M 175.20M 232.40M 285.40M 178.30M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -125.70000M -61.70000M 346.60M -379.20000M -23.20000M
Change to liabilities 31.80M 89.80M 65.00M -65.00000M 29.10M
Total cashflows from investing activities -125.70000M -138.90000M 274.00M -509.70000M -137.80000M
Net borrowings -72.70000M -25.60000M -421.90000M 266.30M 33.50M
Total cash from financing activities -310.40000M -220.70000M -495.10000M 1154.50M -140.90000M
Change to operating activities 31.90M 8.90M -108.90000M 122.40M -13.60000M
Net income 300.60M 289.10M 323.80M -238.30000M 276.70M
Change in cash -73.80000M 19.70M 44.60M 486.40M 17.10M
Begin period cash flow 629.30M 609.60M 565.00M 78.60M 61.50M
End period cash flow 555.50M 629.30M 609.60M 565.00M 78.60M
Total cash from operating activities 362.40M 376.50M 265.40M -157.80000M 296.00M
Issuance of capital stock - 1.10M 2.40M 862.50M 7.40M
Depreciation 71.90M 64.50M 68.80M 66.70M 38.50M
Other cashflows from investing activities -29.80000M -61.70000M 346.60M -379.20000M -23.20000M
Dividends paid 197.40M 194.00M 75.60M 193.70M 181.80M
Change to inventory -41.30000M -54.10000M 7.70M -28.40000M -28.00000M
Change to account receivables -89.00000M -52.20000M -60.80000M 82.50M -4.20000M
Sale purchase of stock -29.60000M -29.60000M 1.70M 219.40M 219.40M
Other cashflows from financing activities -42.10000M -25.60000M -20.50000M 396.30M 219.70M
Change to netincome 23.30M -7.60000M -43.60000M -23.70000M -12.60000M
Capital expenditures 95.90M 77.20M 72.60M 130.50M 114.60M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -130.30000M -106.30000M -53.10000M 54.10M 8.10M
Stock based compensation 15.90M 10.80M 8.10M 7.00M -
Other non cash items -10.10000M 22.90M -127.20000M 13.80M -315.20000M
Free cash flow 266.50M 299.30M 192.80M -288.30000M 181.40M


  • Previous Close 332.16
  • Market Cap21773.31M
  • Volume115727
  • P/E Ratio61.40
  • Dividend Yield1.23%
  • EBITDA519.10M
  • Revenue TTM2149.40M
  • Revenue Per Share TTM32.73
  • Gross Profit TTM 1448.10M
  • Diluted EPS TTM5.32

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
Cochlear Ltd
-1.4 0.42% 330.76 61.40 46.30 9.75 11.76 9.62 36.63
Polynovo Ltd
-0.01 0.41% 2.42 - 140.85 17.37 21.49 17.51 647.42
Anteris Technologies Ltd
0.11 0.58% 19.00 - - 104.23 14.98 95.15 -5.9152
Avita Therapeutics Inc
0.07 2.86% 2.52 - - 8.59 5.71 6.72 -10.0538
Ebr Systems Inc CDR
-0.02 1.90% 1.03 - - - 5.68 -7.482

Reports Covered

Stock Research & News


Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.

Cochlear Ltd

1 University Avenue, Sydney, NSW, Australia, 2109

Key Executives

Name Title Year Born
Mr. Diggory William Howitt BE (Hons), MBA CEO, MD, Pres & Exec. Director 1967
Mr. Stuart Sayers Chief Financial Officer NA
Mr. Jan Janssen MSc Elec Eng Chief Technology Officer 1965
Mr. Anthony Bishop Pres of Asia Pacific & Latin America NA
Ms. Lisa Aubert Pres of North America NA
Mr. Richard Brook MBA Pres of EMEA NA
Mr. David Hackshall Chief Information Officer NA
Ms. Kristina Devon VP of Investor Relations NA
Ms. Jennifer Stevenson VP of Corp. Communications & Brand NA
Mr. Dean Phizacklea Sr. VP of Global Strategic Marketing NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).